Principal Investigator
Aditi Dhir
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20230224
Clinical Trial Summary
A Prospective Phase 3 Study of Patients with Newly Diagnosed Very Low-risk and Low-risk Fusion Negative Rhabdomyosarcoma
Phase
Phase III
Funding Agency/Sponsor
National Cooperative Group
Disease
Pediatric Cancer
Contact Information
Phone Number
305-243-2647